We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KGH:GPWKGHM Polska Miedz S.A. Analysis

Data as of 2026-06-12 - not real-time

€84.07

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

KGHM’s share price of €84.07 sits comfortably above its 20‑day (≈80.84) and 50‑day (≈77.43) moving averages and well above the 200‑day level (≈61.28), signalling a strong bullish bias despite a bearish MACD histogram and a neutral RSI of 56. The stock trades near a technical support zone around 75 and faces resistance near 89, with volume trending upward and 30‑day volatility elevated at roughly 66%, while its computed beta of 0.34 suggests limited market‑wide price swings.
The latest Q1 2026 results delivered a record‑high adjusted EBITDA (more than double YoY) and a net‑profit surge of over 200%, driving a 42% EPS surprise; revenue grew 33% year‑over‑year, profit margin sits at 17.5% and ROE is a healthy 20%. Valuation metrics are attractive – a trailing P/E of 10.4 and a P/B of 0.52 indicate the stock is potentially undervalued, though a high debt‑to‑equity ratio (~17) and negative free cash flow raise concerns about dividend sustainability (yield 0.45%, payout ratio reported as 0). Analyst fair‑value estimates have been nudged upward to PLN 317, aligning with the higher end of the Street target range and reinforcing upside potential.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above key moving averages indicating bullish momentum
  • Strong Q1 earnings beat and rising volume
  • Support level around 75 providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation multiples (P/E 10.4, P/B 0.52)
  • Robust earnings growth and high ROE
  • Fair‑value estimate lifted toward PLN 317, suggesting upside

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term copper demand supporting fundamentals
  • High debt‑to‑equity and negative free cash flow tempering optimism
  • Diversified global asset base reducing geographic concentration risk

Key Metrics & Analysis

Financial Health

Revenue Growth32.80%
Profit Margin17.53%
P/E Ratio10.4
ROE20.13%
ROA7.51%
Debt/Equity16.96
P/B Ratio0.5
Free Cash Flow€-1950875008

Technical Analysis

TrendBullish
RSI56.3
Support€75.00
Resistance€89.08
MA 20€80.84
MA 50€77.43
MA 200€61.28
MACDBearish
VolumeIncreasing
Fear & Greed Index87.61

Valuation

GradeUndervalued
TypeBlend
Dividend Yield0.45%

Risk Assessment

Beta0.34
Volatility66.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.